Figure 1 | Scientific Reports

Figure 1

From: Impact of type of anticoagulant on clinical outcomes in cancer patients who had atrial fibrillation

Figure 1

Pattern of anticoagulant use in cancer patients with atrial fibrillation. Group 1 patients who did not received anticoagulant, group 2 patients who received warfarin before cancer diagnosis, group 3 patients who received DOACs before cancer diagnosis and group 4 patients who received LMWH/UFH before cancer diagnosis. NO AC no anticoagulant, DOAC direct oral anticoagulant, LMWH low-molecular-weight heparin, UFH unfractionated heparin.

Back to article page